QHL Pharmaceuticals

Qinghai qinghai lake pharmaceutical co., ltd. was founded in 1987, the total assets of 460 million yuan, the existing staff of 160 people, has 30 people licorice series product research team, the company's research and development center has been identified as the provincial enterprise technology center.The company has a licorice planting base of 7,000 mu in qinghai, gansu, xinjiang and other regions, and an annual output of 2,000 tons of glycyrrhizic acid production line in Afghanistan.It has successively won the honorary titles of national May Day labor award, model labor relationship harmonious enterprise of qinghai province, worker pioneer numberof all-china federation of trade unions, national high-tech enterprise of qinghai province, double hundredenterprise of the whole province, leading enterprise of agricultural and animal husbandry industrialization of the whole province.Company existing annual annual output of 500 tons of plant extracts, annual output of 100 tons, annual output of 80 tons of glycyrrhetinic acid ammonium single, annual output of 1500 tons of refined Chinese medicine , annual output of 30 tons of potash, a total of six production lines, two main products ephedrine, glycyrrhizic acid, ammonium glycyrrhetate single, liquorice extract of acetylated acid, medicine, Chinese medicine , licorice toothpaste, 18 varieties, including ephedrine products reached the international pharmacopoeia standards.The products sell well in more than 30 domestic pharmaceutical, health care products, cosmetics manufacturers, exported to Europe and the United States, southeast Asia, Taiwan and other 22 countries and regions.In 2017, the company achieved an output value of 297 million yuan, a sales revenue of 270 million yuan, and paid taxes of more than 4 million yuan.During the period of much starker choices-and graver consequences-in, the company will be adhering to the based on the characteristic resources, develop green products, together industry elite, creating health industryconcept of development, with liquorice monomer separation of research and development and deep processing industry for the development direction, efforts to develop high, terminal products, create the characteristics of biological medicine industry group in western China, realize overall listing and make greater contributions to the development of local economy.